Life Scientist > Biotechnology

Dung beetles and the sneaky f…er strategy

01 September, 2008 by Graeme O'Neill

Beetles and crickets offer the perfect model for studying sexual selection and the primacy of female choice.


The motherfish and the stunned mullet

27 August, 2008 by Kate McDonald

The recent announcement of “the oldest mother ever discovered” made headlines around the world for Dr John Long and his colleagues, but Materpiscis Attenboroughi is just one of numerous finds Long has made at the Gogo Formation in WA over the last two decades.


Progen gets strategic advice

27 August, 2008 by Dylan Bushell-Embling

Independent advisory firm to help Progen with planning following termination of PI88 study.


NeuroDiscovery has teeth

27 August, 2008 by Dylan Bushell-Embling

NeuroDiscovery demonstrates effectiveness of NSL-101 in dental surgery


Generic partners India pharma

27 August, 2008 by Dylan Bushell-Embling

Indian pharma Lupin invests in Generic Health


Biota records small year-end loss

27 August, 2008 by Dylan Bushell-Embling

Biota’s long-running legal battle with GSK has taken its toll, with the company recording a $20 million loss for the year.


Horses for courses for Bioeffectives

27 August, 2008 by Dylan Bushell-Embling

Bioeffectives show promise as effective treatment of equine gastric ulcers and as a replacement for antibiotics in poultry feed.


No pain for Xenome

21 August, 2008 by Dylan Bushell-Embling

Synthetic venom peptide shows promise in trials


Spine fusion for Mesoblast

21 August, 2008 by Dylan Bushell-Embling

Mesoblast's stem cells effective method for cervical spine fusion


QRXPharma writes off

21 August, 2008 by Dylan Bushell-Embling

QRxPharma reports $36 million deficit


Market in sight for Pharmaxis

20 August, 2008 by Dylan Bushell-Embling

Pharmaxis concludes Phase 3 trial of Bronchitol


Happy as a pig

20 August, 2008 by Dylan Bushell-Embling

Imugene reports early PRRS vaccine trial results


Anadis fights flu

20 August, 2008 by Dylan Bushell-Embling

Anadis shows proof-of-principle for spray-based 'flu fighter'


Aldridge quits Peplin

19 August, 2008 by Dylan Bushell-Embling

Peplin appoints new CEO and president/CMO


$3 million for Chagas research

15 August, 2008 by Kate McDonald

Murdoch University and Epichem get $3 million Chagas research boost


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd